Abstract
Clinical use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with significant toxicity particularly in the gastrointestinal tract and kidney. Various approaches such as formulation & co-administration (of agents to protect the stomach), chemical manipulation and synthesis of new safer anti-inflammatory drugs reported in the literature to overcome the toxicity of NSAIDs have been summarized. As far as synthesis of new more effective and safer anti-inflammatory drugs is concerned, we have reported recent findings in the area of synthesis of heterocyclic compounds such as pyrimidines, imidazole, benzimidazole, thiazole, thiazolidine, acridine, thiourea, alkanoic acid derivatives and other related heterocyclic compounds and their role as inflammation inhibitors.
Keywords: Heterocyclic compounds, Inflammation inhibitors, nonsteroidal
Current Medicinal Chemistry
Title: Heterocyclic Compounds as Inflammation Inhibitors
Volume: 9 Issue: 10
Author(s): Sham M. Sondhi, Nidhi Singhl, Monika Johar, B.S. Narayan Reddy and J. William Lown
Affiliation:
Keywords: Heterocyclic compounds, Inflammation inhibitors, nonsteroidal
Abstract: Clinical use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with significant toxicity particularly in the gastrointestinal tract and kidney. Various approaches such as formulation & co-administration (of agents to protect the stomach), chemical manipulation and synthesis of new safer anti-inflammatory drugs reported in the literature to overcome the toxicity of NSAIDs have been summarized. As far as synthesis of new more effective and safer anti-inflammatory drugs is concerned, we have reported recent findings in the area of synthesis of heterocyclic compounds such as pyrimidines, imidazole, benzimidazole, thiazole, thiazolidine, acridine, thiourea, alkanoic acid derivatives and other related heterocyclic compounds and their role as inflammation inhibitors.
Export Options
About this article
Cite this article as:
Sondhi M. Sham, Singhl Nidhi, Johar Monika, Reddy Narayan B.S. and Lown William J., Heterocyclic Compounds as Inflammation Inhibitors, Current Medicinal Chemistry 2002; 9 (10) . https://dx.doi.org/10.2174/0929867024606678
DOI https://dx.doi.org/10.2174/0929867024606678 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pigment Epithelium-Derived Factor (PEDF) Blocks Angiotensin IIInduced T Cell Proliferation by Suppressing Autocrine Production of Interleukin-2
Medicinal Chemistry Follicular Cysts: A Single Sign and Different Diseases. A View from Comparative Medicine
Current Pharmaceutical Design Epigenetic Targeting of Platinum Resistant Testicular Cancer
Current Cancer Drug Targets Combining Drug and Immune Therapy: A Potential Solution to Drug Resistance and Challenges of HIV Vaccines?
Current HIV Research TRIM65 in White Matter Lesions, Innate Immunity, and Tumor
Current Molecular Pharmacology Effects of Iron Polymaltose Complex, Ferrous Fumarate and Ferrous Sulfate Treatments in Anemic Pregnant Rats, Their Fetuses and Placentas
Inflammation & Allergy - Drug Targets (Discontinued) Implication of Prophetic Variables and their Impulsive Interplay in CA Prostate Patients Experiencing Osteo-Metastasis
Anti-Cancer Agents in Medicinal Chemistry Oncolytic Viruses for Induction of Anti-Tumor Immunity
Current Pharmaceutical Biotechnology A System Review of Anti-fibrogenesis Effects of Compounds Derived from Chinese Herbal Medicine
Mini-Reviews in Medicinal Chemistry In Vivo Osteoarthritis Target Validation Utilizing Genetically-Modified Mice
Current Drug Targets Sofosbuvir: Really Meets the Unmet Needs for Hepatitis C Treatment?
Infectious Disorders - Drug Targets Protective Immunity in Humans: A Glimpse Provided by the Analysis of Herpesvirus-Specific T Cells in Health and Disease
Current Immunology Reviews (Discontinued) In Silico Studies Most Employed in the Discovery of New Antimicrobial Agents
Current Medicinal Chemistry Antitumor Effects of Interferon-Alpha on Cell Growth and Metastasis in Human Nasopharyngeal Carcinoma
Current Cancer Drug Targets Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Cytopenias in HIV Infection: Mechanisms and Alleviation of Hematopoietic Inhibition
Current HIV Research Cysteine-, Methionine- and Seleno-Cysteine-Proline Chimeras: Synthesis and Their Use in Peptidomimetics Design
Current Bioactive Compounds Patent Selections
Recent Patents on DNA & Gene Sequences